July 31, 2018 / 5:19 AM / in 4 months

Fresenius nudges up Kabi earnings guidance

BERLIN, July 31 (Reuters) - Fresenius SE nudged up its earnings guidance for its Kabi generics unit on Tuesday as it posted a 3 percent rise in adjusted group net profit in the second quarter.

The German healthcare group now expects earnings before interest and tax (EBIT) growth at Kabi in the range of -2 to +1 percent. It had previously forecast EBIT to decline between 6 and 3 percent.

It confirmed its full-year guidance for adjusted group sales to expand between 5 and 8 percent this year, while adjusted net income is expected to grow between 6 and 9 percent.

Second-quarter sales fell 2 percent to 8.4 billion euros ($9.84 billion), while net income before special items rose 3 percent to 472 million euros, slightly ahead of the average poll forecast for 467 billion euros. ($1 = 0.8535 euros) (Reporting by Caroline Copley Editing by Maria Sheahan)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below